An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.

Please provide your email address to receive an email when new articles are posted on . Individually tailored immunosuppressive therapy may help preserve vision in at least one eye in children with ...

Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...

Please provide your email address to receive an email when new articles are posted on . Uveitis describes inflammation that exists in the uveal tract, but the disease course has such a variety of ...

Vitreous cysts are rare structural entities that have been reported sporadically in the literature. Several associations have been described, including retinitis pigmentosa, Toxoplasmosis, trauma, ...

Q. I’m 64 and have been diagnosed with uveitis in my right eye. What causes it, and what’s the best treatment? A. Uveitis is inflammation of one or more of the parts of the uvea, the layer of tissue ...

Expert Rev Ophthalmol. 2012;7(6):587-594. Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations ...

An international coalition of eye researchers used machine learning to develop classification criteria for 25 of the most common types of uveitis, a collection of over 30 diseases characterized by ...